Honasa Consumer vs Emami business model compares direct-to-consumer beauty brand portfolio built around Mamaearth against personal care combined with Ayurvedic healthcare product diversification to see which personal care fmcg has better business model.

Suven Pharmaceuticals (Cohance) vs Laurus Labs business model compares concentrated specialty pharma intermediate and CDMO manufacturing against diversified pharmaceutical manufacturing spanning API, generics and CDMO services to see which pharma cdmo has better business model.

GIC Re vs ICICI Lombard business model compares PSU reinsurance underwriting risk transferred from primary insurers against diversified private general insurance underwriting across multiple categories to see which insurance has better business model.

Medi Assist Healthcare Services vs New India Assurance business model compares third-party claims administration and processing services for insurers against PSU general insurance underwriting across multiple product categories to see which health insurance ecosystem has better business model.

New India Assurance vs ICICI Lombard growth compares PSU direct general insurance underwriting across multiple product categories against private diversified general insurance underwriting with digital distribution to see which general insurance has better growth.

Nifty Pharma index falls close to 2 percent today with Gland Pharma, Piramal Pharma and Aurobindo Pharma leading declines. Check the full list of top losers here.

Honasa Consumer vs Godrej Consumer Products business model compares direct-to-consumer beauty brand portfolio built around Mamaearth against household and personal care diversification with international operations to see which personal care fmcg has better business model.

Mahanagar Gas vs Indraprastha Gas business model compares concentrated Mumbai metropolitan city gas distribution with dense network against concentrated Delhi NCR city gas distribution with dense network to see which city gas distribution has better business model.

Sai Life Sciences vs Laurus Labs business model compares concentrated CDMO services for global innovator pharmaceutical companies against diversified pharmaceutical manufacturing spanning API, generics and CDMO services to see which pharma cdmo has better business model.